![Professor Sir Stephen Bloom, executive chairman of Zihipp, hopes the drug will combat the global obesity 'tsunami'. Mark Chilvers for The National](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/L3WNKLZTSZFRRA4GOWPXOTY2HI.jpg?smart=true&auth=b2d9b52313e3866d2ed63e37961979196f90033f217c3f5ffb58a211175741ac&width=400&height=225)
Professor Sir Stephen Bloom, executive chairman of Zihipp, hopes the drug will combat the global obesity 'tsunami'. Mark Chilvers for The National
Professor Sir Stephen Bloom, executive chairman of Zihipp, hopes the drug will combat the global obesity 'tsunami'. Mark Chilvers for The National
UAE-backed UK biotech firm Zihipp takes aim at global obesity
Imperial College spin-out now in trial phase of revolutionary drug thanks to Mubadala funding